Target Class Profiling of Small-Molecule Methyltransferases

被引:1
|
作者
Hanson, Quinlin M. [1 ]
Hoxie, Nate [1 ]
Shen, Min [1 ]
Guo, Hui [1 ]
Cho, Ig-Jun [1 ]
Chakraborty, Ipsita [1 ]
Aragon, Brooklyn M. [1 ]
Rai, Ganesha [1 ]
Patnaik, Samarjit [1 ]
Janiszewski, John S. [1 ]
Hall, Matthew D. [1 ]
机构
[1] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA
基金
美国国家卫生研究院;
关键词
CATECHOL-O-METHYLTRANSFERASE; GLYCINE N-METHYLTRANSFERASE; PROTEIN METHYLTRANSFERASES; DRUG DISCOVERY; INHIBITORS; PLATFORM; BINDING; CANCER; ASSAY; PNMT;
D O I
10.1021/acschembio.3c00124
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Target class profiling (TCP) is a chemical biology approach to investigate understudied biological target classes. TCP is achieved by developing a generalizable assay platform and screening curated compound libraries to interrogate the chemical biological space of members of an enzyme family. In this work, we took a TCP approach to investigate inhibitory activity across a set of small-molecule methyltransferases (SMMTases), a subclass of methyltransferase enzymes, with the goal of creating a launchpad to explore this largely understudied target class. Using the representative enzymes nicotinamide N-methyltransferase (NNMT), phenylethanolamine N-methyltransferase (PNMT), histamine N-methyltransferase (HNMT), glycine N-methyltransferase (GNMT), catechol O-methyltransferase (COMT), and guanidinoacetate N-methyltransferase (GAMT), we optimized high-throughput screening (HTS)-amenable assays to screen 27,574 unique small molecules against all targets. From this data set, we identified a novel inhibitor which selectively inhibits the SMMTase HNMT and demonstrated how this platform approach can be leveraged for a targeted drug discovery campaign using the example of HNMT.
引用
收藏
页码:969 / 981
页数:13
相关论文
共 50 条
  • [41] Small-molecule mimetics
    Murcko, M
    DRUG DISCOVERY TODAY, 1996, 1 (10) : 408 - 410
  • [42] Phage display technology for target determination of small-molecule therapeutics: an update
    Takakusagi, Yoichi
    Takakusagi, Kaori
    Sakaguchi, Kengo
    Sugawara, Fumio
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (10) : 1199 - 1211
  • [43] Impact of target interactions on small-molecule drug disposition: an overlooked area
    van Waterschoot, Robert A. B.
    Parrott, Neil J.
    Olivares-Morales, Andres
    Lave, Thierry
    Rowland, Malcolm
    Smith, Dennis A.
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (04) : 299 - +
  • [44] Impact of target interactions on small-molecule drug disposition: an overlooked area
    Robert A. B. van Waterschoot
    Neil J. Parrott
    Andrés Olivares-Morales
    Thierry Lavé
    Malcolm Rowland
    Dennis A. Smith
    Nature Reviews Drug Discovery, 2018, 17 : 299 - 299
  • [45] A Small-Molecule Probe with a Dual Function of miRNA Inhibition and Target identification
    Wang, Weishan
    Deng, Jiafang
    Zhang, Yan
    Li, Jinbo
    CHEMISTRY-A EUROPEAN JOURNAL, 2023, 29 (03)
  • [46] Degradation of target protein in living cells by small-molecule proteolysis inducer
    Zhang, D
    Baek, SH
    Ho, A
    Kim, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) : 645 - 648
  • [47] Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends
    Fabini, Edoardo
    Manoni, Elisabetta
    Ferroni, Claudia
    Del Rio, Alberto
    Bartolini, Manuela
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (08) : 901 - 921
  • [48] The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs
    Vernall, Andrea J.
    Hill, Stephen J.
    Kellam, Barrie
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1073 - 1084
  • [49] The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA
    Gu, Long
    Lingeman, Robert
    Yakushijin, Fumiko
    Sun, Emily
    Cui, Qi
    Chao, Jianfei
    Hu, Weidong
    Li, Hongzhi
    Hickey, Robert J.
    Stark, Jeremy M.
    Yuan, Yate-Ching
    Chen, Yuan
    Vonderfecht, Steven L.
    Synold, Timothy W.
    Shi, Yanhong
    Reckamp, Karen L.
    Horne, David
    Malkas, Linda H.
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 6053 - 6065
  • [50] Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
    Khan, Nagma
    Jeffers, Michael
    Kumar, Sampath
    Hackett, Craig
    Boldog, Ferenc
    Khramtsov, Nicholai
    Qian, Xiaozhong
    Mills, Evan
    Berghs, Stanny C.
    Carey, Nessa
    Finn, Paul W.
    Collins, Laura S.
    Tumber, Anthony
    Ritchie, James W.
    Jensen, Peter Buhl
    Lichenstein, Henri S.
    Sehested, Maxwell
    BIOCHEMICAL JOURNAL, 2008, 409 : 581 - 589